Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: systematic review and network meta-analysis

Pas encore traduit Pas encore traduit
Catégorie Structured summary of systematic reviews
JournalDatabase of Abstracts of Reviews of Effects (DARE)
Year 2013
Loading references information

CRD SUMMARY:

This review of 12 randomised controlled trials found that oral anticoagulants (dabigatran, rivaroxaban, apixaban and vitamin K antagonists) and antiplatelet agents (acetylsalicylic acid) were associated with a reduced recurrence of venous thromboembolism compared with placebo or observation. This finding is likely to be reliable but comparisons of individual treatments may be misleading given uncertainties inherent in the available evidence base.
Epistemonikos ID: e5cd406a9d9b4b1215468611e9f2643d9a715363
First added on: Jan 13, 2015